145720.KS
Dentium Co. Ltd.
KSC · Healthcare · Medical - Instruments & Supplies · KR
KRW 37,250.00
+1.50%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 348.1B | 346.5B | 407.8B | 393.2B | 355.9B |
| Cost of Revenue | 133.0B | 140.6B | 147.6B | 114.3B | 95.2B |
| Gross Profit | 215.1B | 205.8B | 260.3B | 278.8B | 260.7B |
| Operating Expenses | |||||
| R&D Expense | 3.0B | 4.5B | 7.6B | 6.9B | 5.6B |
| SG&A Expense | 106.4B | 62.7B | 76.4B | 64.6B | 57.0B |
| General & Admin Expense | 11.7B | 14.7B | 15.7B | 16.0B | 14.3B |
| Selling & Marketing Expense | 49.8B | 48.0B | 60.6B | 48.6B | 42.6B |
| Other Expenses | 38.1B | 76.4B | 77.8B | 69.1B | 72.4B |
| Total Operating Expenses | 147.5B | 143.6B | 161.8B | 140.6B | 135.0B |
| Cost and Expenses | 280.5B | 284.2B | 309.3B | 255.0B | 230.1B |
| Operating Income (EBIT) | 67.6B | 62.2B | 98.5B | 138.3B | 125.7B |
| Non-Operating | |||||
| Interest Income | 3.6B | 1.6B | 1.1B | 1.3B | 683.4M |
| Interest Expense | 10.8B | 10.7B | 9.6B | 7.4B | 6.8B |
| Net Interest Income | (7.2B) | (9.1B) | (8.5B) | (6.1B) | (6.1B) |
| Other Non-Op Income/Expense | (12.4B) | (38.9B) | (4.6B) | (3.8B) | (7.3B) |
| Non-Operating Income (excl Interest) | 18.3B | — | (5.0B) | (3.6B) | 514.9M |
| EBT (Pre-Tax Income) | 55.2B | 23.3B | 93.9B | 134.5B | 118.4B |
| Income Tax Expense | 25.0B | 6.6B | 21.5B | 38.0B | 32.3B |
| Bottom Line | |||||
| Net Income | 30.5B | 16.8B | 72.7B | 96.5B | 86.1B |
| Earnings from Cont. Ops | 30.2B | 16.7B | 72.4B | 96.5B | 86.1B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 30.5B | 16.8B | 72.7B | 96.5B | 86.1B |
| Per Share | |||||
| Basic EPS | ₩3,570 | ₩1,948 | ₩8,430 | ₩11,192 | ₩9,980 |
| Diluted EPS | ₩3,570 | ₩1,948 | ₩8,430 | ₩11,192 | ₩9,980 |
| Revenue Per Share | ₩40,429 | ₩40,173 | ₩47,287 | ₩45,593 | ₩41,265 |
| Shares | |||||
| Basic Shares Outstanding | 8.6M | 8.6M | 8.6M | 8.6M | 8.6M |
| Diluted Shares Outstanding | 8.6M | 8.6M | 8.6M | 8.6M | 8.6M |
| Profitability Metrics | |||||
| EBITDA | 96.2B | 87.4B | 126.7B | 162.8B | 141.0B |
| D&A | 27.0B | 25.2B | 23.2B | 20.9B | 15.8B |
| EBIT | 69.2B | 62.2B | 103.5B | 141.9B | 125.2B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026